We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

185 hedge funds and large institutions have $860M invested in SANGAMO THERAPEUTICS INC in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 39 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 39

67% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $15.7M

36% more capital invested

Capital invested by funds: $630M → $860M (+$230M)

4.74% more ownership

Funds ownership: 64.51% → 69.25% (+4.7%)

6% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 31

1% less funds holding

Funds holding: 187 → 185 (-2)

Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
76
Reduced
39
Closed
31
Calls
$26.2M
Puts
$15.7M
Net Calls
+$10.5M
Net Calls Change
+$2.07M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$71.5M
2
BG
Bellevue Group
Switzerland
+$38.8M
3
Citadel Advisors
Citadel Advisors
Florida
+$17.6M
4
BlackRock
BlackRock
New York
+$11.7M
5
N
Nuveen
North Carolina
+$8.41M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$9.23M
2
State Street
State Street
Massachusetts
-$5.37M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.96M
4
Bank of America
Bank of America
North Carolina
-$2.07M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
SLG
101
Stanley-Laman Group
Pennsylvania
$291K – – –
VCWA
102
Vanguard Capital Wealth Advisors
Colorado
$270K +$21.3K +2,000 +9%
Legal & General Group
103
Legal & General Group
United Kingdom
$252K +$31.7K +2,980 +15%
Walleye Capital
104
Walleye Capital
New York
$244K +$230K +21,599 +1,964%
SG Americas Securities
105
SG Americas Securities
New York
$229K +$226K +21,238 New
VRS
106
Virginia Retirement Systems
Virginia
$225K +$26.6K +2,500 +14%
Public Employees Retirement Association of Colorado
107
Public Employees Retirement Association of Colorado
Colorado
$219K – – –
Cambridge Investment Research Advisors
108
Cambridge Investment Research Advisors
Iowa
$210K +$2.13K +200 +1%
AB
109
Amalgamated Bank
New York
$210K +$42.1K +3,958 +25%
AAM
110
Advisors Asset Management
Colorado
$198K -$4.86K -457 -2%
Comerica Bank
111
Comerica Bank
Texas
$188K – – –
XK
112
Xact Kapitalforvaltning
Sweden
$188K – – –
Balyasny Asset Management
113
Balyasny Asset Management
Illinois
$186K +$184K +17,264 New
WCM
114
Weld Capital Management
New York
$180K +$178K +16,710 New
TSS
115
Two Sigma Securities
New York
$177K +$175K +16,471 New
USAA
116
United Services Automobile Association
Texas
$175K – – –
Commonwealth Equity Services
117
Commonwealth Equity Services
Massachusetts
$156K -$11.5K -1,081 -7%
CWM
118
Cedar Wealth Management
California
$154K – – –
LTFS
119
Ladenburg Thalmann Financial Services
Florida
$151K +$7.73K +727 +5%
OAM
120
Oppenheimer Asset Management
New York
$151K +$10.7K +1,003 +8%
Prudential Financial
121
Prudential Financial
New Jersey
$149K +$13.5K +1,270 +10%
FSA
122
Franklin Street Advisors
North Carolina
$138K +$9.36K +880 +7%
RJFSA
123
Raymond James Financial Services Advisors
Florida
$136K +$6.4K +602 +5%
LPL Financial
124
LPL Financial
California
$134K -$7.45K -700 -5%
BNP Paribas Financial Markets
125
BNP Paribas Financial Markets
France
$133K -$104K -9,781 -44%
3 4
5
6 7

SGMO Hedge Fund Activity: Q2 2019 in Review

185 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2019, worth a combined $860M — up 36% from $630M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SGMO positions and 31 closed out — a net gain of 2 holders — while 76 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $71.5M. The largest seller was Invesco, cutting an estimated $9.23M.

  • 185 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2019, down from 187 in Q1 2019.
  • Funds reported $860M of SANGAMO THERAPEUTICS INC stock for Q2 2019, up 36% quarter-over-quarter.
  • 33 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2019 and 31 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2019 was Wellington Management Group, an estimated $71.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2019 was Invesco, an estimated $9.23M sold.

Based on aggregated 13F filings for Q2 2019.